Literature DB >> 19063999

Blood pressure and the risk for dementia: a double edged sword.

Sean P Kennelly1, B A Lawlor, R A Kenny.   

Abstract

Alzheimer's disease (AD) and vascular dementia (VaD) are important causes of cognitive decline in the elderly. As a result of the aging population, the incidence of dementia is expected to increase substantially over the coming decades. Many studies have identified that vascular risk factors are implicated in the pathogenesis of both AD and VaD. Longitudinal studies have suggested that high blood pressure in midlife is associated with a higher incidence of both AD and VaD in later life. The association appears weaker for hypertension in later life. Some studies also suggest that hypotension; especially low diastolic blood pressure in late-life is also associated with an increased risk of AD. Long-standing hypertension may lead to severe atherosclerosis and impaired cerebrovascular autoregulation. A decline in blood pressure in later life may contribute to diminished cerebral perfusion. The subsequent ischaemic state may lead to increased cerebral beta-amyloid accumulation.

Entities:  

Mesh:

Year:  2008        PMID: 19063999     DOI: 10.1016/j.arr.2008.11.001

Source DB:  PubMed          Journal:  Ageing Res Rev        ISSN: 1568-1637            Impact factor:   10.895


  65 in total

Review 1.  Alzheimer's Disease: The Link Between Amyloid-β and Neurovascular Dysfunction.

Authors:  Ernesto Solis; Kevin N Hascup; Erin R Hascup
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

Review 2.  Vascular aspects of cognitive impairment and dementia.

Authors:  Maximilian Wiesmann; Amanda J Kiliaan; Jurgen A H R Claassen
Journal:  J Cereb Blood Flow Metab       Date:  2013-09-11       Impact factor: 6.200

Review 3.  A heartfelt message, estrogen replacement therapy: use it or lose it.

Authors:  Robert C Speth; Mikayla D'Ambra; Hong Ji; Kathryn Sandberg
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-09-14       Impact factor: 4.733

4.  Different Relationship Between Systolic Blood Pressure and Cerebral Perfusion in Subjects With and Without Hypertension.

Authors:  Lidia Glodzik; Henry Rusinek; Wai Tsui; Elizabeth Pirraglia; Hee-Jin Kim; Anup Deshpande; Yi Li; Pippa Storey; Catherine Randall; Jingyun Chen; Ricardo S Osorio; Tracy Butler; Emily Tanzi; Molly McQuillan; Patrick Harvey; Stephen K Williams; Gbenga Ogedegbe; James S Babb; Mony J de Leon
Journal:  Hypertension       Date:  2019-01       Impact factor: 10.190

Review 5.  Hot Topics in Research: Preventive Neuroradiology in Brain Aging and Cognitive Decline.

Authors:  C A Raji; H Eyre; S H Wei; D E Bredesen; S Moylan; M Law; G Small; P M Thompson; R M Friedlander; D H Silverman; B T Baune; T A Hoang; N Salamon; A W Toga; M W Vernooij
Journal:  AJNR Am J Neuroradiol       Date:  2015-06-04       Impact factor: 3.825

6.  Nonlinear blood pressure effects on cognition in old age: separating between-person and within-person associations.

Authors:  Valgeir Thorvaldsson; Ingmar Skoog; Scott M Hofer; Anne Börjesson-Hanson; Svante Ostling; Simona Sacuiu; Boo Johansson
Journal:  Psychol Aging       Date:  2011-10-10

7.  Accounting for bias due to selective attrition: the example of smoking and cognitive decline.

Authors:  Jennifer Weuve; Eric J Tchetgen Tchetgen; M Maria Glymour; Todd L Beck; Neelum T Aggarwal; Robert S Wilson; Denis A Evans; Carlos F Mendes de Leon
Journal:  Epidemiology       Date:  2012-01       Impact factor: 4.822

8.  Charlson Comorbidity Index, inappropriate medication use and cognitive impairment : Bermuda Triangle.

Authors:  Kamile Silay; Ahmet Yalcin; Sema Akinci; Fatma Gul Gursoy; Didem Sener Dede
Journal:  Wien Klin Wochenschr       Date:  2017-09-01       Impact factor: 1.704

9.  Intensive control of hypertension and risk of Alzheimer's dementia in older adults with depression.

Authors:  Anthony Yeung; Alex Kiss; Damien Gallagher
Journal:  Int J Geriatr Psychiatry       Date:  2020-04-21       Impact factor: 3.485

10.  Pinpointing key mechanisms in Alzheimer's disease development.

Authors:  Julie Williams
Journal:  Alzheimers Res Ther       Date:  2010-03-31       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.